Skip to main content
THERAGEN ETEX CO.,LTD. logo

THERAGEN ETEX CO.,LTD. — Investor Relations & Filings

Ticker · 066700 ISIN · KR7066700006 KO Manufacturing
Filings indexed 193 across all filing types
Latest filing 2024-08-01 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 066700

About THERAGEN ETEX CO.,LTD.

http://www.theragenetex.com/

THERAGEN ETEX CO.,LTD. is a biotechnology and pharmaceutical group focused on genome-based personalized and precision medicine. The company integrates advanced genomic analysis with pharmaceutical development and manufacturing. Its genomics division provides comprehensive genetic analysis services, leveraging pioneering achievements such as creating the world's first female and tiger genome maps and commercializing Asia's first individual genome analysis service. The pharmaceutical division develops and supplies medicines from its international GMP-certified facilities. The R&D pipeline focuses on incrementally modified drugs, orphan drugs, and novel anticancer therapies, including its proprietary drug candidate, Vactosertib, which is in clinical trials for various cancers.

Recent filings

Filing Released Lang Actions
타법인주식및출자증권취득결정(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Teragen Etex regarding the acquisition of shares in another company (CytoGen). It details the acquisition amount, purpose, and board approval, which falls under M&A activity or corporate investment. Since it specifically details the acquisition of shares in another entity, it is classified as M&A Activity (TAR).
2024-08-01 Korean
생산중단
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from Teragen Etex regarding a temporary suspension of production due to a regulatory administrative penalty (violation of the Pharmaceutical Affairs Act). It details the nature of the suspension, the impact on sales, and the duration of the manufacturing halt. Since this is a specific regulatory announcement regarding operational status and legal/regulatory compliance that does not fit into categories like M&A, dividends, or financial reports, it is classified as a Regulatory Filing (RNS).
2024-07-23 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the first quarter of 2024 (제 35 기 1분기) for the company Theragen Etex. It contains detailed financial statements, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice regarding a change in the company's listing category (from 'Mid-sized Enterprise' to 'Blue-chip Enterprise') on the stock exchange. It does not fit into specific financial reporting categories like 10-K or IR, nor is it a report publication announcement. As it is a general regulatory notification regarding corporate status, it falls under the RNS (Regulatory Filings) category.
2024-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (Annual General Meeting). It details the approval of financial statements, dividend resolutions, and the election of directors. This falls under the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it provides the outcome of the voting process at the AGM.
2024-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of Board/Management Information, as it specifically details changes to the company's board composition.
2024-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.